Tandem Labs was built on partnerships with pharmaceutical companies providing creative methods development and validation of hundreds of proprietary compounds. We are currently building our suite of validated assays and welcome requests for assays that meet your specific needs.
Validated non-proprietary assays currently offered:
| List of Validated Assays | |||||
|---|---|---|---|---|---|
| ALL | A-F | G-L | M-R | S-Z | |
| COMPOUND | MATRIX | CALIBRATION RANGE | Anti-Coag | LTMS | TEMP |
|---|---|---|---|---|---|
| Maraviroc | Human Plasma | 1.00 - 1,000 ng/mL | K2EDTA | 180 | -20 |
| Mefenamic acid | Human Plasma | 50.0 - 5,000 ng/mL | K3EDTA | 119 | -70 |
| Memantine | Human Plasma | 0.100 - 100 ng/mL | K3EDTA | 429 | -20 |
| Mesalamine | Human Plasma | 2.00 to 1000 ng/mL | |||
| Metformin | Human Plasma | 5.00 - 5,000 ng/mL | K3EDTA | 56 days | -70 |
| R,S-Methadone | Human Plasma | 5.00 - 1,000 ng/mL | K3EDTA | 240 | -20 |
| Methotrexate / 7-Hydroxymethotrexate | Human Plasma | 1.00 - 500 ng/mL | NaEDTA | 527 | -20 |
| Methotrexate / 7-Hydroxymethotrexate | Human Plasma | 1.00 - 500 ng/mL | K2EDTA | 59 | -20 |
| Methotrexate / 7-Hydroxymethotrexate | Human Plasma | 1.00 - 500 ng/mL | K2EDTA | 50 | -70 |
| Methotrexate / 7-Hydroxymethotrexate | Human Urine | 1,000 - 50,000 ng/mL 50.0 - 2,500 ng/mL |
None | 89 | -20 |
| 1-Methyluric acid | Human Urine | 2,500 - 20,000 ng/mL | None | 131 | -20 |
| 1-Methyluric acid | Human Urine | 2,500 - 20,000 ng/mL | None | 131 | -70 |
| 1-Methylxanthine / 1,7-Dimethyluric acid | Human Urine | 500 - 20,000 ng/mL | None | 21 | -20 |
| 1-Methylxanthine / 1,7-Dimethyluric acid | Human Urine | 500 - 50,000 ng/mL | None | 21 | -20 |
| Metoprolol | Human Plasma | 0.500 - 250 ng/mL | Heparin/EDTA | 121 | -20,-70 |
| Midazolam / 1-Hydroxymidazolam | Human Plasma | 0.100 - 10.0 ng/mL | K2EDTA | 1093 | -20 |
| Midazolam / 1-Hydroxymidazolam / 4-Hydroxymidazolam |
Human Plasma | 0.100 - 50.0 ng/mL | K2EDTA | 117 | -20 |
| Moexipril / Hydrochlorothiazide | Human Plasma | 1.00 - 200 ng/mL | K2EDTA | 36 | -70 |
| Morphine / Morphine-6-glucuronide | Human Plasma | 0.500 - 100 ng/mL 2.5 - 500 ng/ml |
K2EDTA | 462 | -20 |
| Morphine / Morphine-3-glucuronide / Morphine-6-glucuronide | Human Plasma | 0.500 - 50.0 ng/mL 10.0 - 1,000 ng/mL 1.00 - 100 ng/mL |
|||
| Moxifloxacin | Human Plasma | 25.00 - 5,000 ng/mL | K2EDTA | 94 | -20 |
| Moxifloxacin | Human Plasma | 25.00 - 5,000 ng/mL | NaHep | 175 | -20 |
| Moxifloxacin | Human Plasma | 25.00 - 5,000 ng/mL | Lithium Heparin | 30 days | -70,-20 |
| Naltrexone / Naltrexol | Human Plasma | 20.0 - 2,000 pg/mL 0.500 - 50.0 ng/mL |
K2EDTA | 174 | -70 |
| Naltrexone / Naltrexol | Human Plasma | 4.00 - 4,000 pg/mL 0.250 - 250.0 pg/mL |
K2EDTA | 35 | -20 |
| Nelfinavir | Human Plasma | 1.00 - 1,000 ng/mL | K3EDTA | 100 | -20 |
| Nicotine/Cotinine | Human Plasma | 1.00 - 500 ng/mL 2.00 - 1,000 ng/mL |
EDTA | 184,~481 | -20,-70 |
| Nifedipine | Human Plasma | 1.00 - 250 ng/mL | K2EDTA | 277 | -20 |
| Nilotinib | Human Plasma | 5.00 - 2,000 ng/mL | K2EDTA | 102 | -20 |
| Nisoldipine | Human Plasma | 50.0 - 10,000 pg/mL | K2EDTA | 288 | -20 |
| Octreotide | Human Plasma | 50.0 - 20,000 pg/mL | |||
| Olanzapine | Human Plasma | 0.400 - 100 nM | K2EDTA | 234 | -20 |
| Omeprazole / 5-Hydroxyomeprazole | Human Plasma | 10.0 - 1,000 ng/mL | K3EDTA | 141 | -20 |
| Oxycodone | Human Plasma | 0.200 - 100 ng/mL | EDTA | 97 | -20 |
| Oxymorphone | Human Plasma | 0.0500 - 25.0 ng/mL | EDTA | 97 | -20 |
| Paclitaxel | Human Plasma | 10.0 - 2,000 ng/mL | K3EDTA | 433 | -20 |
| Paclitaxel | Human Plasma | 10.0 - 5,000 ng/mL | K2EDTA | 164 | -20,-70 |
| Paliperidone (9-Hydroxy Risperidone) | Human Plasma | 0.100 - 100 nM | |||
| Pramipexole | Human Plasma | 50.0 - 5,000 pg/mL | K3EDTA | 35 | -20 |
| Pregabalin | Human Plasma | 50.0 - 20,000 ng/mL | K2EDTA | 538 | -20 |
| Quetiapine | Human Plasma | 0.500 - 2,000 ng/mL | K2EDTA | 194,3 | -20,-70 |
| Raltegravir | Human Plasma | 1.00 - 1,000 ng/mL | |||
| Ramelteon | Human Plasma | 50.0 - 8,000 pg/mL | K2EDTA | 95 | -20 |
| Ranolazine | Human Plasma | 5.00 - 5,000 ng/mL | K2EDTA | Pending | -20,-70 |
| Ribavarin | Human Plasma | 5.00 - 5,000 ng/mL | K2EDTA | 191 | -20,-70 |
| Rifaximin | Human Plasma | 0.100 - 10.0 ng/mL | K2EDTA | 448 | -20 |
| Riluzole | Human Plasma | 5.00 - 2,000 ng/mL | K3EDTA | -20 | |
| Riluzole | Dried Blood Spot | 5.00 - 2,000 ng/mL | |||
| Risperidone / 9-Hydroxy Risperidone (Paliperidone) | Human Plasma | 0.400 - 100 nM | K2EDTA | 219 | -20 |
| Rosiglitazone | Human Plasma | 1.00 - 1,000 ng/mL | K2EDTA |